Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

Published:2023-04 Issue:7 Volume:16 Page:829-843
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Lee Seung Hun^ORCID,Jeong Young-Hoon^ORCID,Hong David,Choi Ki Hong,Lee Joo Myung,Park Taek Kyu,Yang Jeong Hoon,Hahn Joo-Yong,Choi Seung-Hyuck,Gwon Hyeon-Cheol,Jeong Myung Ho,Kim Byeong-Keuk,Joo Hyung Joon,Chang Kiyuk,Park Yongwhi,Ahn Sung Gyun,Suh Jung-Won,Lee Sang Yeub,Cho Jung Rae,Her Ae-Young,Kim Hyo-Soo,Kim Moo Hyun,Lim Do-Sun,Shin Eun-Seok^ORCID,Song Young Bin^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. 2018 ESC/EACTS guidelines on myocardial revascularization;Neumann;Eur Heart J,2019

4. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;Collet;Eur Heart J,2021

5. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Lawton;J Am Coll Cardiol,2022

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A type of self-assembled and label-free DNA-modified electrochemical biosensors based on magnetic α-Fe2O3/Fe3O4 heterogeneous nanorods for ultra-sensitive detection of CYP2C19*3;Bioelectrochemistry;2024-12

2. Impact of proton pump inhibitor use on clinical outcomes in East Asian patients receiving clopidogrel following drug-eluting stent implantation;BMC Medicine;2024-08-15

3. Prognostic Impact of CYP2C19 Genotypes on Long‐Term Clinical Outcomes in Older Patients After Percutaneous Coronary Intervention;Journal of the American Heart Association;2024-05-21

4. Genotype-guided prescribing predictors in CYP2C19 intermediate metabolizers receiving percutaneous coronary intervention;Pharmacogenomics;2024-05-02

5. Aiming for precision: CYP2C19 gene polymorphism and clopidogrel resistance in patients with peripheral artery disease;Thrombosis Research;2024-04